Class information for:
Level 1: LONIDAMINE//IONIDAMINE//ADVANCED BREAST CANCER CHEMOTHERAPY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
23035 304 28.4 61%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1701 6131 INTERNATIONAL JOURNAL OF HYPERTHERMIA//ISOLATED LIMB PERFUSION//LONIDAMINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LONIDAMINE Author keyword 142 79% 30% 92
2 IONIDAMINE Author keyword 4 67% 1% 4
3 ADVANCED BREAST CANCER CHEMOTHERAPY Author keyword 1 100% 1% 2
4 ANTISPERMATOGENIC DRUGS Author keyword 1 100% 1% 2
5 LONIDAMINE AND BREAST CANCER Author keyword 1 100% 1% 2
6 LONIDAMINE THERAPY Author keyword 1 100% 1% 2
7 MALE PUBERTAL MICE Author keyword 1 100% 1% 2
8 MITOMYCIN C DRUG COMBINATION Author keyword 1 100% 1% 2
9 TOLNIDAMINE Author keyword 1 100% 1% 2
10 EHRLICH TUMOR CELLS Author keyword 1 30% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 LONIDAMINE 142 79% 30% 92 Search LONIDAMINE Search LONIDAMINE
2 IONIDAMINE 4 67% 1% 4 Search IONIDAMINE Search IONIDAMINE
3 ADVANCED BREAST CANCER CHEMOTHERAPY 1 100% 1% 2 Search ADVANCED+BREAST+CANCER+CHEMOTHERAPY Search ADVANCED+BREAST+CANCER+CHEMOTHERAPY
4 ANTISPERMATOGENIC DRUGS 1 100% 1% 2 Search ANTISPERMATOGENIC+DRUGS Search ANTISPERMATOGENIC+DRUGS
5 LONIDAMINE AND BREAST CANCER 1 100% 1% 2 Search LONIDAMINE+AND+BREAST+CANCER Search LONIDAMINE+AND+BREAST+CANCER
6 LONIDAMINE THERAPY 1 100% 1% 2 Search LONIDAMINE+THERAPY Search LONIDAMINE+THERAPY
7 MALE PUBERTAL MICE 1 100% 1% 2 Search MALE+PUBERTAL+MICE Search MALE+PUBERTAL+MICE
8 MITOMYCIN C DRUG COMBINATION 1 100% 1% 2 Search MITOMYCIN+C+DRUG+COMBINATION Search MITOMYCIN+C+DRUG+COMBINATION
9 TOLNIDAMINE 1 100% 1% 2 Search TOLNIDAMINE Search TOLNIDAMINE
10 EHRLICH TUMOR CELLS 1 30% 1% 3 Search EHRLICH+TUMOR+CELLS Search EHRLICH+TUMOR+CELLS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IONIDAMINE 31 92% 4% 12
2 PLUS LONIDAMINE 14 100% 2% 7
3 ANTINEOPLASTIC DRUG LONIDAMINE 6 71% 2% 5
4 INDAZOLE CARBOXYLIC ACIDS 3 100% 1% 3
5 LONIDAMINE 3 18% 4% 13
6 AGENT LONIDAMINE 2 50% 1% 3
7 5 BROMO 2 DEOXY URIDINE 1 100% 1% 2
8 INVIVO CONTROL 1 100% 1% 2
9 DRUG LONIDAMINE 1 50% 0% 1
10 GERM CELL MITOCHONDRIA 1 50% 0% 1

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors 2003 62 48 90%
Pharmacokinetics and metabolism of lonidamine in rats: Evidence of enterohepatic recycling 1997 2 12 100%
Recent studies on lonidamine, the lead compound of the antispermatogenic indazol-carboxylic acids 2002 8 17 71%
The adenine nucleotide translocator: A new potential chemotherapeutic target 2003 24 47 19%
Mitochondrion as a novel target of anticancer chemotherapy 2000 312 139 5%
Mitochondria as targets for established and novel anti-cancer agents 2001 47 65 9%
Chemotherapy: targeting the mitochondrial cell death pathway 2002 246 169 3%
Mitochondria as a target for inducing death of malignant hematopoietic cells 2003 30 136 6%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ASL6 1 50% 0.3% 1
2 EXPTL CHEMOTHER Y 1 50% 0.3% 1
3 HUMAN BIOPATHOL HAEMATOL 1 50% 0.3% 1
4 PNEUMOONCOL 5 1 50% 0.3% 1
5 SECT RECH CYTOGENET MOL ONCOL 1 50% 0.3% 1
6 SPECIAL SPECIES MED 1 50% 0.3% 1
7 UNITE MIXTE RECH 147 0 33% 0.3% 1
8 CAECIS 0 25% 0.3% 1
9 MED DIPARTIMENTO MED SPERIMENTALE 0 25% 0.3% 1
10 PHARMACOL NAT SUBSTANCES GEN PHYSIOL 0 13% 0.7% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000117862 DIACEREIN//DIACERHEIN//DIACETYLRHEIN
2 0.0000103800 PHLIP//TUMOR ACIDITY//TUMOR PH
3 0.0000098131 WHOLE BODY HYPERTHERMIA//THERMOCHEMOTHERAPY//INTRACELLULAR PLATINUM UPTAKE
4 0.0000088453 INDAZOLES//2H INDAZOLES//INDAZOLE
5 0.0000082180 GLUTATHIONE DOXORUBICIN CONJUGATE//RAT HEPATOMA CELL//SIMULTANEOUS IMMOBILIZATION
6 0.0000067587 WARBURG EFFECT//PKM2//3 BROMOPYRUVATE
7 0.0000060959 MARY M WOHLFORD MALE CONTRACEPT//ECTOPLASMIC SPECIALIZATION//BLOOD TESTIS BARRIER
8 0.0000049107 THERMORADIOSENSITIZATION//THERMAL RADIOSENSITIZATION//LONG DURATION MILD HYPERTHERMIA
9 0.0000047777 AGED RELATED CHANGES//AGEING RAT//HISTOENZYMIC DISTRIBUTION
10 0.0000044251 HIGH DOSE CHEMOTHERAPY//DOSE INTENSITY//HIGH RISK BREAST CANCER